Showing results (101-110 of 331) with videos related to
Sort By:
Pageof 34
The International Journal on Drug Policy|December 23, 2015
Sexual identity and prevalence of alcohol and other drug use among Australians in the general populationAmanda Roxburgh, Toby Lea, John de Wit, et al.The International Journal on Drug Policy|February 5, 2020
Drugs as technologies of the self: Enhancement and transformation in LGBTQ culturesKiran Pienaar, Dean Anthony Murphy, Kane Race, et al.Journal of Psychopharmacology (Oxford, England)|February 16, 2021
Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intentionRotem Petranker, Thomas Anderson, Larissa J Maier, et al.The American Journal on Addictions|June 19, 2004
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation TrialNicholas Lintzeris, Alison Ritter, Mary Panjari, et al.Journal of Clinical and Experimental Neuropsychology|April 25, 2017
Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive AssessmentNicole Ridley, Jennifer Batchelor, Brian Draper, et al.Drug and Alcohol Dependence|July 13, 2007
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patientsNicholas Lintzeris, Timothy B Mitchell, Alyson J Bond, et al.Addiction (Abingdon, England)|November 1, 2014
Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocolLouisa Degenhardt, Briony Larance, Raimondo Bruno, et al.Epilepsy & Behavior : E&B|December 26, 2021
Determination of contaminants in artisanal cannabis products used for childhood epilepsy in the Australian community: A sub-analysis of the 'PELICAN' studyAnastasia Suraev, Melissa J Benson, Lewis Martin, et al.Drug and Alcohol Review|February 28, 2013
Factors influencing pharmacy services in opioid substitution treatmentBetty B Chaar, Holly Wang, Carolyn A Day, et al.Drug and Alcohol Dependence|April 26, 2015
The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) studyLouisa Degenhardt, Raimondo Bruno, Robert Ali, et al.Pageof 34